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Enrichment of Murine and Human Langerhans Cells with Solid Phase 
lmmunoabsorption Using Pan-Leukocyte Monoclonal Antibodies 
G ARY S. WOOD , M .D. , JON KOSEK , M.D ., E UGEN E C. B UTCHER, M .D ., AND V ERA B MORHENN , M .D . 
Departments of Dermatology (GS W, VBM) and Pathology (JK, ECB), S tanford University Medical School, Stanford, California, U.S.A. 
Using a solid phase immunoabsorption (panning) tech-
nique, we have employed pan-leukocyte monoclonal an-
tibodies to e nrich and deplete murine and human Lan-
gerhans cells from cell suspensions of normal skin. Lan-
gerhans cell-enriched fractions contained 80-99% 
mononuclear cells, almost all of which had the ultra-
structural features of Langerhans cells. These results 
are compara ble to those achieved by panning for human 
Langerhans cells with anti-Leu-6(T6) antibody. Simi-
larly , less than 1 % of these cells were detectable in 
Langerhans cell-depleted fractions and such fractions 
were incapable of stimulating allogeneic lymphocytes in 
the skin ce ll-lymphocyte reaction. We conclude that pan-
ning with pan-leukocyte antibodies is an effective means 
of enriching or depleting Langerhans cells from heter-
ogeneous skin cell suspensions and can y ield results 
similar to those achieved with more Langerhans cell-
specific reagents such as anti-Leu-6(T6). These findings 
are of particular significance to the enrichment and 
depletion of murine Langer hans cells since they express 
no know n correlate of the human Leu-6(T6) a ntigen. 
Prior studies have documen ted t hat so lid phase immunoab-
so rpt ion (pa nning) is a stra ight forward a nd effi cien t m eans of 
enrichin g or depleting selected cell types from heterogeneous 
p opulations (1 ,2]. Highly enriched a nd depleted prepa rations 
of huma n L a ngerha ns cells have bee n obtained by pa nning 
w it h a n t i-L eu -6(T6) an t ibodies whose specific ity is restricted 
to L a ngerha ns cells a nd indeterminate cells wit hin norma l skin 
(2 ]. U nfortunately, murine L a ngerha ns cells express no known 
correlate of t he hum a n L eu- 6(T 6) a n t igen . Al ternatives such 
as an t i-Ia a n t ibodies risk poten t ia l loss of ra - L a ngerha ns cell 
subsets [3- 6] a nd contamination by other Ia+ skin cells such 
as endothelium (5, 7], acrosyringium [5,8], a nd possibly othe r 
keratinocytes [9]. 
Employing immunoul t ras tructura l methods, we have re-
cen t ly dem onstrated t hat monoclona l a n t ibody L 3B12 reacts 
w it h L a ngerha ns cells [10] . This reage nt is one of a series of 
!Jan-leukocyte monoclo nal a n t ibodies whose reactivity is re-
stricted to bone ma rrow-de rived cells of leukocytic lineage [10-
15]. These a n t ibodies prec ipi tate major ba nds in t he 200,000 
Mr ra nge a nd react wit h a fa mily of ce ll surface a n t igens kn own 
co llectively as t he leukocyte common an t igen (10-15 ]. U nlike 
t he L eu-6(T 6) a nt igen , a correlate of t he huma n leukocyte 
common a n t igen ex ists in mice a nd in rats where it is termed 
t he murine T 200 [12] a nd t he leukocyte comm on [13] a n t igen , 
respective ly. 
In t he presen t study, we provide light microscopic evidence 
fo r t he reactivity of murine La ngerha ns ce lls wi t h a nti-T 200 
m on oclona l a n t ibody a nd confirm our prior obse rvations con -
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cerning t he reactivity of huma n Langerhans cells with pa n -
leukocyte m onoclona l a ntibodies. We t hen dem onstrate t hat 
t hese reagents can be employed in p anning techniques to effec-
t ively enrich or deplete murine as well as huma n Langerha ns 
cells from heterogeneous skin cell populations. 
MATERIALS AND ME THODS 
Monoclonal Antibodies 
Rat anti-mouse 30G12 (ant i-T 200) [16] was provided by L. A. 
Herzenberg, Stanford University. 
Two mouse antihuman monoclonal antibodies directed against t he 
leukocyte common antigen were employed. L3B12 [10,15] was provided 
by Ronald Levy, Stanfo rd Univers ity; 2D1 [11] was provided by Becton-
Dickinson, Mountain View, Cali fo rnia. 
Immunohistologic Staining 
Murine skin biopsies were obtained from BALB/c mice. Human skin 
biopsies were selected from the frozen t issue library of the Laboratory 
of T issue lmmunodiagnosis at Stanford. Within a few hours of biopsy, 
representative unfixed portions were snap-frozen, cryostat-sectioned, 
and acetone-fixed. Human biopsies were subsequently stained with a 
t hree-stage monoclonal antibody biotin -avidin immunoperoxidase 
technique as described previously [1 7]. Murine biopsies were stained 
with rabbi t ant irat lg (affi ni ty purified) followed by a horseradish 
peroxidase conjugate of swine antirabbit lg (Dako). Controls included 
substi tution of first-stage reagents with irre levant monoclonal antibod-
ies and staining wi th one or more stages deleted. 
Solid Phase l mmunoabsorption 
Single cell suspensions of normal human ski n obtained at surgery 
and normal murine skin obtained from newborn BALB/c mice were 
prepared as described previously [2,18,19]. T hese ce ll suspensions were 
t hen incubated with t he appropriate pan-leukocyte ant ibody, washed, 
and panned in plastic Petri dishes coated with an appropriate second-
stage an tiserum as described previously [1,2,20]. For huma,n cells, 
dishes 've re coated wi th goat antimouse immunoglobulin (Tago, Tnc., 
Burlingame, California). For murine cells, dishes were coated with 
affini ty-purified rabbit ant irat !g. Cells adherent to dishes were eit her 
examined in situ or gently scraped off with a rubber policeman and 
resuspended fo r functional studies. 
Skin Cell-Lymphocyte reaction (SLR) 
The SLR was performed as descri bed previously [2,19,21]. Briefly, 5 
x 10' human peripheral blood mononuclear ce lls obtained from healthy 
volun teers were coincubated in microtiter plates with 5 X 10' allogeneic 
human skin cells. After mainta ining the cul tures for 6 days, [3H] 
thymidine was added and the plates were harvested 18 h later. All 
SLRs were performed in t riplicate using lymphocytes from healthy 
donors unrelated to the skin donors. 
Electron Microscopy 
Murine and human skin cells adherent to panning dishes were 
[:: luteralde hyde-fi xed in situ and routinely processed fo r t ransmission 
or sca nning electron microscopy while t hey remai ned attached to the 
plastic dishes. T hick and thin sections were cut from Epon blocks 
which had been snapped off t he dish surfaces and contained the panned 
adherent cell monolayer. 
RESULTS 
Frozen Section. Immunohistology 
Usin g immunoperoxidase techn iques, cyrostat sections of 
murine a nd human skin were stained with m onoclo nal anti bod-
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F IG I. Human skin stained with pan-leu kocyte antibody L3B12. 
Dendritic cells with in the hair foll icle infund ibular epithelium (center) 
and adjacent epidermis are L3Bl2+. Intradermal leukocytes and den-
dritic cell. are also L3B12+. Cryostat sect ion with methylene blue 
counterstain , X 300. 
-
FIG 2. Murine skin stained with anti-T200 antibody 30G12. Den-
drit ic ce lls within the hair fo llicle infundibu lar epithelium (right) and 
adjacent ep idermi s are 30Gl2+. Intrade rmal leukocytes and dendri tic 
cells are also 30G 12+. Cryostat section with methylene blue counter 
stain , x 300. 
ies d irected against murine T200 a nd human leukocyte common 
a ntigens, respectively. Rat antimouse 30Gl2 and mouse ant i-
huma n L3Bl2 a nd 2Dl were employed. Each an t ibody stained 
a popu lation of intraepiderm a l, suprabasil a r dendritic cells 
morphologically characteristic of Langerhans cell s (Figs 1, 2). 
Add it iona l leukocytes wit hin t he dermis were a lso sta ined. 
Morphologic Features of Epidermal Cells Fractionated by 
Panning 
In o rder to dete rmine whether pan- leukocyte antibody reac -
t ivity could be exploited to enrich and deplete Langerhans ce lls 
from skin , murine and huma n epide rm al cell suspensions were 
pan ned with 30Gl2 a nd L3B12, respectively. Wright-Giemsa-
sta ined cyto logic preparat ions of adherent a nd nonadherent 
ce ll fract ions were examined under oil immersion a t 1500X. 
Cells adherent to pann ing plates were a lso embedded in Epon 
in situ and examined by light a nd electron m icroscopy. Less 
tha n 1% leukocytes were detec ted in t he nonadherent cell 
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fract ion. From 80- 99% of adherent ce lls were nonkeratinocyte 
mononuclear cell s . Alt hough scattered leuk ocytes we re identi-
fi ed, most of t hese cells ex hibi ted ultrastructural features of 
Langerhans cells a nd indete rm inate cells (Figs 3, 4). They 
contained nucle i wit h irregular contours, sparse cytoplasmic 
organelles, and numerous dendrit ic processes. Birbeck gra nules 
F IG 3. Representative adherent cell obtai ned by panning hu man 
skin cell suspensions with L3B12. T he characteristic features of the 
Langer hans cell are evident including numerous Birbeck granules. Thin 
section stained with uranyl acetate and lead citrate. Bar= 1 11m. 
-F IG 4. Representative adherent cells obtained by panning murine 
skin cell suspensions wi th 30G 12. Virtually all cells had the ul trastruc-
tural features of dendritic cells. Birbeck granules were present in many 
of these cells in random sections (inset) . Thin section stained wi th 
uyranyl acetate and lead citrate. Bar= 2 11m , inset bar = 0.25 11m . 
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were identified in several of these cells in random thin sections. 
Scanning electron microscopy of t he adherent fraction dem-
onstrated cells with topographic features similar to t hose de-
scribed previously for other types of dendritic cells [22 ] (Fig 5). 
Functional Studies of Epidermal Cells Fractionated by Panning 
Morphologic studies indicated that panning with pan- leuko-
cyte antibodies was an effective means of enriching and deplet-
ing Langerhans cells from epidermal cell suspensions. In order 
to determine t he efficacy of t his fractionation technique from 
a funct ional standpoint, we assayed the abi li ty of L3B12-
panned fractions of human epidermal ce lls to stimulate allo-
gen eic lymp hocytes in t he SLR. As detailed in Table I, the 
L3B12-adherent (leukocyte-enriched) fraction elicited strong 
responder activi ty while t he nonadherent (leukocyte-depleted) 
fraction produced no significant activity above autologous con-
t rol background. Thus, both morphologic and fu nctional pa-
rameters indicated t hat a high degree of enrichment or deple-
t ion of immune-reactive mononuclear cells from other epider-
mal cells could be achieved with th is panning technique. 
Qu.antitation of Epidermal Cells Fractionated by Panning 
In two separate experiments beginning with 1.33 X 108 and 
1.38 x 108 viable human epidermal cells, the yield of viable 
cells following resuspension of L3B12-adherent cells was 1.5 X 
106 (1.1 %) and 2.9 x 10'1 (2.1 %), respectively. The viability of 
the resuspended cells was 77 % and 80%, respectively. 
FIG 5. Adherent cell obtained by panni ng murine skin cell suspen· 
sions with 30G 12. Scanning electron microscopic features characte ristic 
of dendritic cells are present including a relatively smooth surface 
co ntou r and numerous, we ll -developed dendritic processes. Long bar= 
11'm· 
TABLE I. Comparison af the capacity of L38 12-enriched and L38 12-
depleted hu.man shin eel/$ to stimulate allogeneic ly mphocytes 
Type of Response of ullo~e neic PBML (cpm)" 
ce lls• Donor A Donor B Donor C Donor D 
U n fractionated 55,809 39,926 23,21 7 39,432 
L3B12-enriched 84,673 81,526 34,866 58,375 
L3B 12-depleted 13,336 13,242 4,397 7,371 
Autologous control 12,265 16,872 4,171 3,111 
Allogeneic control 53,0(18 50,192 23,979 28,034 
" Mean of tripl icate values; the SEM was less than 1.5 % for all va lues. 
b Skin cells (5 X 10'/ well) were incubated with 5 X 10' PBML 
(Periphera l blood mononuclear leukocytes) from donors A- D. Similar 
results were obtained in a second experiment also incorporating 4 
donors. 
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DISCUSSION 
The data indicate t hat murine and human Langerhans cells 
react with antibodies directed against the T200 or leukocyte 
common antigen. The reactivity of human Langerhans cells 
wit h two different pan-leukocyte monoclonal antibodies is 
strong evidence for expression of the leukocyte common antigen 
by Langerhans cell s as opposed to cross reactivity of the anti-
bodies with some other cell surface antigen. Human Langer-
hans cell reactivity with L3B12 has recently been documented 
at t he ultrastructural level [10] and serves to corroborate prior 
chimera studies indicating that murine Langerhans cells are 
bone marrow derived [23,24]. Detailed analysis of human Lan-
gerha ns cell an t igen and enzyme expression [10,25,26] and 
functional characteristics [27,28] also indicate that these cells 
are specia lized leukocytes most closely related to other Ia+ 
dendritic cells, which function as potent accessory cells in 
immune responses [27,29]. 
P rior studies have demonstrated that individual subpopula-
tions can be enriched from epidermal cell suspensions by Per-
co il gradient centrifugation [30], velocity sedimentation [31], 
fluorescence-activated cel l sorting [19,20], and panning [2,20]. 
Of these methods, panning has proved to be the most straight-
forward, inexpensive, and efficient. Panning with anti-Leu-
6(T6) has yielded from 70% to greater than 90% pure La nger-
hans cell preparations in our laboratory [2] . The current data 
indicate that panning of epidermal cell s from normal (noni n-
flamed) skin with pan-leukocyte reagents results in similar 
yields with only rare contaminating leukocytes or other cell 
ypes . In addition, as with anti-Leu-6(T6) panning [2], t he 
10nadherent cell fract ion is effectively depleted of cells capable 
•f stimulating allogeneic lymphocytes in the SLR. Because 
pan -leukocyte an tibodies react with virtually all leukocytes (10-
15], panning with these reagents could also be employed to 
deplete or enrich heterogeneous leukocytes from inflamed skin 
samples, whereas repeated panning with a panel of leukocyte 
subset antibodies would otherwise be required to achieve a 
simi lar result. 
T here is no recognized equiva lent to t he human Leu-6(T6) 
antigen that is known to be expressed by murine Langerhans 
cell s. The current data indicate t hat t he T200 reactivity of 
these cells can be exploited through panning to yield highly 
enriched or depleted preparations of murine Langerhans cells. 
Anti-T200 pann ing has t heoretical advantages ove r anti -Ia 
panning which cou ld potentia lly collect endothelial and ot her 
nonleukocyte cell types in addition to Langerhans cells [5-9]. 
Furthermore, recent data suggest that Ia antigen is not ex-
pressed by all Langerhans cells, at least in normal human skin 
[3- 6] whereas immunoultrastructu ral data indicate that human 
Langerhans ce lls are uniformly reactive with pan- leukocyte 
monoclona l antibody L3B1 2 [10]. 
The authors are indebted t.o Eva Pfendt and Kay Lee Frank for 
expert technical assistance and Richard Coffin for photographic assis-
tance. E. C. B. is a scholar of the Leukemia Society of America. 
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